当前位置: X-MOL 学术BJOG An Int. J. Obstet. Gynaecol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Optimising Anti‐D Use: Revisiting Guidelines for First Trimester Abortions
BJOG: An International Journal of Obstetrics & Gynaecology ( IF 4.7 ) Pub Date : 2024-11-07 , DOI: 10.1111/1471-0528.17996
Katherine C. Whitehouse, Patricia A. Lohr, John Reynolds‐Wright, Jonathan Lord, Stephen Robson, Tracey Masters, Yvonne Neubauer, Lydia Kingsley, Sharon Cameron

Conflicts of Interest

Katherine C. Whitehouse: Evidence Advisor for British Society of Abortion Care Providers, Editor for European Society of Contraception and Reproductive Health journal, Consultant for World Health Organization. Patricia A. Lohr: Member of NICE Abortion Care Guideline Committee, Chair of British Society of Abortion Care Providers Education and Training Committee, Advisory Panel for Abortion Talk, Associate Editor for BMJ Sexual and Reproductive Healthcare. John Reynolds-Wright: Associate editor of BMJ Sexual and Reproductive health, received educational grants from Gedeon Richter to attend meetings in Europe, received research grant funding from Exelgyn (Nordic Pharma) and HRA Pharma (Perrigo) for projects unrelated to this current work, Evidence Advisor for British Society of Abortion Care Providers. Jonathan Lord: co-chair RCOG abortion taskforce; co-chair British Society of Abortion Care Providers; Commission on Human Medicines (CHM) member medicines for women's health expert advisory group (MWHEAG) (Medicines and Healthcare products Regulatory Agency (MHRA)); National Institute for Health and Care Excellence (NICE) NHS Clinician Representative (Abortion care: quality standard (QS199) and clinical guideline (NG140)). Stephen Robson: Nothing to declare. Tracey Masters: co-chair British Society of Abortion Care Providers. Yvonne Neubauer: Nothing to declare. Lydia Kingsley: Nothing to declare. Sharon Cameron: editor in chief BMJ SRH, PI for FHI 360 funded study on progestogen-only injectable, European scientific advisory board member on very early medical abortion funded by Exelgyn, France.



中文翻译:


优化抗 D 抗体的使用:重新审视孕早期流产指南


 利益冲突


Katherine C. Whitehouse:英国堕胎护理提供者协会的证据顾问、欧洲避孕和生殖健康学会杂志的编辑、世界卫生组织的顾问。Patricia A. Lohr:NICE 堕胎护理指南委员会成员、英国堕胎护理提供者协会教育和培训委员会主席、堕胎谈话咨询小组、BMJ 性与生殖保健副主编。John Reynolds-Wright:BMJ Sexual and Reproductive health 的副主编,获得 Gedeon Richter 的教育资助参加欧洲会议,获得 Exelgyn (Nordic Pharma) 和 HRA Pharma (Perrigo) 的研究资助,用于与当前工作无关的项目,英国堕胎护理提供者协会的证据顾问。乔纳森·洛德(Jonathan Lord):RCOG堕胎工作组联合主席;英国堕胎护理提供者协会联合主席;人类药物委员会 (CHM) 女性健康药物专家咨询小组 (MWHEAG)(药品和保健产品监管局 (MHRA));国家卫生与临床优化研究所 (NICE) NHS 临床医生代表(堕胎护理:质量标准 (QS199) 和临床指南 (NG140))。Stephen Robson:没什么好宣布的。特蕾西·马斯特斯(Tracey Masters):英国堕胎护理提供者协会(British Society of Abortion Care Providers)联合主席。Yvonne Neubauer:没什么好宣布的。Lydia Kingsley:没什么好宣布的。Sharon Cameron:BMJ SRH 主编,FHI 360 资助的仅孕激素注射剂研究的 PI,法国 Exelgyn 资助的极早期药物流产欧洲科学顾问委员会成员。

更新日期:2024-11-07
down
wechat
bug